BioStem Technologies, Inc.
BSEM
$3.71
$0.102.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.72% | 21.68% | -1,579.53% | 7,080.19% | -99.73% |
| Total Depreciation and Amortization | 25.65% | 504.39% | -14.56% | 27.16% | 15.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -33.51% |
| Total Other Non-Cash Items | 90.93% | -89.14% | 891.92% | -39.74% | 21.97% |
| Change in Net Operating Assets | -104.64% | 2,180.13% | 94.01% | -261.51% | 252.44% |
| Cash from Operations | -570.93% | -129.19% | 218.65% | -143.95% | 33.10% |
| Capital Expenditure | -3,016.67% | 99.59% | 81.93% | -627.32% | -101.82% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | -- | -- |
| Cash from Investing | 99.63% | -3,338.69% | 62.59% | -251.26% | -101.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 83.69% | -803.34% |
| Issuance of Common Stock | -- | -- | -100.00% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 100.00% | 85.32% | -1,242.48% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 57.46% | -762.75% | 164.87% | -188.38% | 8.58% |